Towards the development of a therapeutic vaccine for the treatment of HIV-1 infection: are we closer than ever?
Egan
Michael A
MA
D016915:AIDS Vaccines / Q000276:immunology / Q000627:therapeutic use*; D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D002986:Clinical Trials as Topic; D003713:Dendritic Cells / Q000276:immunology; D015658:HIV Infections / Q000453:epidemiology / Q000276:immunology / Q000628:therapy* / Q000821:virology; D015497:HIV-1 / Q000276:immunology* / Q000502:physiology; D006801:Humans; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D019444:Vaccines, DNA / Q000276:immunology / Q000627:therapeutic use*; D019562:Viral Load
D016915:AIDS Vaccines; D019444:Vaccines, DNA